These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2596601

  • 1. Plasma norepinephrine in humans: limitations in assessment of whole body norepinephrine kinetics and plasma clearance.
    Henriksen JH, Christensen NJ.
    Am J Physiol; 1989 Nov; 257(5 Pt 1):E743-50. PubMed ID: 2596601
    [Abstract] [Full Text] [Related]

  • 2. Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kinetics.
    Eisenhofer G, Esler MD, Goldstein DS, Kopin IJ.
    Am J Physiol; 1991 Oct; 261(4 Pt 1):E505-15. PubMed ID: 1928342
    [Abstract] [Full Text] [Related]

  • 3. Tracer norepinephrine kinetics: dependence on regional blood flow and the site of infusion.
    Grossman E, Chang PC, Hoffman A, Tamrat M, Kopin IJ, Goldstein DS.
    Am J Physiol; 1991 May; 260(5 Pt 2):R946-52. PubMed ID: 2035707
    [Abstract] [Full Text] [Related]

  • 4. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure.
    Davis D, Baily R, Zelis R.
    Am J Physiol; 1988 Jun; 254(6 Pt 1):E760-6. PubMed ID: 3377075
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
    Veith RC, Best JD, Halter JB.
    J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
    [Abstract] [Full Text] [Related]

  • 7. Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans.
    Willemsen JJ, Ross HA, Jacobs MC, Lenders JW, Thien T, Swinkels LM, Benraad TJ.
    Clin Chem; 1995 Oct; 41(10):1455-60. PubMed ID: 7586517
    [Abstract] [Full Text] [Related]

  • 8. Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d,l-[3H]isoproterenol kinetics in essential hypertension.
    Goldstein DS, Horwitz D, Keiser HR, Polinsky RJ, Kopin IJ.
    J Clin Invest; 1983 Nov; 72(5):1748-58. PubMed ID: 6630523
    [Abstract] [Full Text] [Related]

  • 9. Age differences in the plasma clearance mechanisms for epinephrine and norepinephrine in humans.
    Morrow LA, Linares OA, Hill TJ, Sanfield JA, Supiano MA, Rosen SG, Halter JB.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):508-11. PubMed ID: 3624412
    [Abstract] [Full Text] [Related]

  • 10. Comparison of norepinephrine and isoproterenol clearance in congestive heart failure.
    Leuenberger U, Kenney G, Davis D, Clemson B, Zelis R.
    Am J Physiol; 1992 Jul; 263(1 Pt 2):H56-60. PubMed ID: 1636772
    [Abstract] [Full Text] [Related]

  • 11. Muscle sympathetic activity and norepinephrine release during mental challenge in humans.
    Hjemdahl P, Fagius J, Freyschuss U, Wallin BG, Daleskog M, Bohlin G, Perski A.
    Am J Physiol; 1989 Nov; 257(5 Pt 1):E654-64. PubMed ID: 2596596
    [Abstract] [Full Text] [Related]

  • 12. Different desipramine-sensitive pulmonary removals of plasma epinephrine and norepinephrine in dogs.
    Eisenhofer G, Smolich JJ, Esler MD.
    Am J Physiol; 1992 Mar; 262(3 Pt 1):L360-5. PubMed ID: 1550259
    [Abstract] [Full Text] [Related]

  • 13. Norepinephrine kinetics and cardiac output during nonhypotensive lower body negative pressure.
    Baily RG, Leuenberger U, Leaman G, Silber D, Sinoway LI.
    Am J Physiol; 1991 May; 260(5 Pt 2):H1708-12. PubMed ID: 2035690
    [Abstract] [Full Text] [Related]

  • 14. Estimation of sympathetic activity in essential hypertension.
    Brown MJ, Lhoste FJ, Zamboulis C, Ind PW, Jenner DA, Dollery CT.
    Clin Pharmacol Ther; 1982 Jan; 31(1):16-22. PubMed ID: 7053299
    [Abstract] [Full Text] [Related]

  • 15. Increased spillover and reduced clearance both contribute to rise in plasma catecholamines after birth in lambs.
    Smolich JJ, Cox HS, Eisenhofer G, Esler MD.
    Am J Physiol; 1996 Feb; 270(2 Pt 2):H668-77. PubMed ID: 8779844
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA, Ward K, Malpass T, Stratton J, Halter J, Evans M, Beiter H, Harker LA, Porte D.
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Norepinephrine metabolism in humans. Kinetic analysis and model.
    Linares OA, Jacquez JA, Zech LA, Smith MJ, Sanfield JA, Morrow LA, Rosen SG, Halter JB.
    J Clin Invest; 1987 Nov; 80(5):1332-41. PubMed ID: 3316275
    [Abstract] [Full Text] [Related]

  • 20. Plasma clearance, metabolism, and tissue accumulation of 3H-labeled catecholamines in trout.
    Nekvasil NP, Olson KR.
    Am J Physiol; 1986 Mar; 250(3 Pt 2):R519-25. PubMed ID: 3953858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.